Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 36

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 samples COVID-19 SARS swabs load plasma children mers-cov sewage BAL exacerbations hcws hbov hbov1 OPS
2 respiratory nucleic sars-cov nasal viral load dogs hcovs pertussis sars-cov-2 fluid interval cats PARV4 oral dpcr
3 patients sars-cov-2 RNA collection viral feces RTI east workers CMV odds nested olfactory oral fluid BKV
4 % acid illness flocked HRV horses AGE middle wards hadv confidence interval faecal hbov2 HEV NPS
5 study negative diarrhea NP loads canine wupyv rrt-pcr disinfection bronchoalveolar clearance virus isolation genotype mrna bocavirus
6 positive test igg influenza shedding HIV-1 npas middle east respiratory syndrome coronavirus environmental lavage ratio first-line B19 ° RT-PCR
7 detected 2019-ncov antibodies throat high equine % saudi surfaces lung odds ratio KD asthmatics stabilizing human
8 PCR 2019 acute respiratory syndrome respiratory viruses viral loads infected acute gastroenteritis arabia case-patients hpev = MS SARI norovirus fns
9 infection RT-PCR viral rna self-collected copies/ml transmission M. saudi arabia viable ventilator‐associated isolations SHAPU subjects acute hbov1 infection NW
10 detection swabs syndrome viruses log10 tissue m. pneumoniae mers-cov. saliva FARP confidence fcov hbov3 HHV-6 peripheral blood mononuclear cells
11 symptoms CT severe MT × SAFV stool 2014 transmission DNS 95%CI ocular etiologic VIDISCA-NGS cces
12 results china antibody NS prolonged ecov CI mers-cov infection household real‐time concentration storage nasal discharge non-acute cells
13 real-time treatment urine swab associated with genus pneumoniae bordetella isolation wards fumigatus viral feline anosmia −20 assay
14 cases positive weeks CF viremia signs stool samples upe contacts APMV + isolation HIV acute samples extraction
15 polymerase 2020 stool collected HCT 229E mcpyv patient 1 staffs RT‐PCR viral isolations fluids PVOD stabilizing agent urinary
16 tract false serum virus hydroxychloroquine camels gastroenteritis sputum H7N9 DIF influenza VF fbov hbov1 dna respiratory pathogens
17 chain wuhan specimens throat swab RV diversity gastrointestinal sputum samples healthcare antibiotic oseltamivir uveitis gastroenteritis sub-genomic sera
18 tested oropharyngeal week nasal swab pandemic exposure rotavirus suspicion live resequencing nontreated effusions persistent EV109 excretion
19 reaction swab detectable foam fatal HCV KIV relatives protective inc. aor OME hbovs agent rna extraction method
20 clinical patients cov washes LRT parvovirus WUV tracheal aspirates hospitals A. viral clearance assays human bocavirus fluid conventional
21 virus rate igm respiratory virus quantitative HKU1 95 PBS household contacts ventilator‐associated pneumonia convalescent transcriptase-polymerase asthma non‐severe bocavirus 1
22 2 nasopharyngeal swabs blood flocked swabs recipients vertical asymptomatic failure serial ICH glucocorticoid carried study subjects CNS febrile
23 presence anal coronavirus rhinovirus H1N1 genetically symptomatic patient pool © V+ faecal samples olfactory dysfunction genomic rt-pcr assay
24 identified throat onset respiratory = infective NPA tracheal equipment IPA NB+ anelloviruses ISOA human bocavirus 1 epithelial
25 viruses oropharyngeal swabs urine specimens % URT pig hcov-hku1 died COVID‐19 microarray viral rna AMON dysfunction genomic rna infect
26 infections pharyngeal response versus logistic respiratory signs found syndrome fragment bronchoalveolar lavage day kidney stable microbial pharyngitis
27 nasopharyngeal positive rate early sensitivity duration proposed stools 2013 precautions bronchoalveolar lavage fluid RNA multiple specimens etiologic agent co-detection reaching
28 specimens results acute mould viral shedding unexplained FS renal health care workers a. fumigatus symptom parechovirus immunodeficiency herpesvirus optimize
29 methods reported serum samples ERV3 ct nasal mucosa AB NALC poultry sepsis‐like illness enrolled FIP complained sole 1-specific
30 14 nucleic acid assay metapneumovirus wheezing vertical transmission human coronaviruses b. pertussis EPS virol factors review psychophysical mini ribonucleic
31 3 sars-cov-2 infection sars-cov infection discomfort quantified BRSV tonsils homogenization H7N4 result cohort MEE cattle central powerful
32 upper days replication impact students mucosa WU orf1a nosocomial transplant stool specimens highly hbov dna incubated tanzanian
33 conclusions disease serological assay nasal swabs untreated reinfection kipyv cohort patient-collected DNA case patients qrt-pcr rhinoviral primarily messenger
34 1 throat swabs viral yield allogeneic nasal hcov-oc43 inconclusive personal recipients bronchiectasis infectious reovirus swine HSCT
35 acute coronavirus disease 2019 features specimen rhinitis fomites merkel DTT viable virus aspergillus influenza rna ‐ human causative agent loading
36 pathogens confirmed sars-cov rna rayon human rhinovirus bcov coronaviruses xylosoxidans tongue syndromes VSP n-pcr characterized rneasy extensive
37 12 combination pbmcs NAT 10(4 nasal secretions DNA cohort 1 contamination stem staff-collected intra-vitam controls CAP method
38 viral IQR viral replication saliva specimens included contact hadv dna LD-PCR sars-cov-2 rna respiratory syndrome inflammatory carriers acoustic rhinometry agents immunoglobulin
39 suspected anal swab neutralizing throat swabs 10(7 bats gastrointestinal illness pk-dnase specimen commensal deviation hcov-nh thailand rtis NPA
40 objective stage fecal specimens mid-turbinate immune couples mo case-patient isolation dna load 16.7 anellovirus hiv-uninfected online version fecal
41 aspirates sars-cov-2 nucleic acid days influenza virus peak cachavirus 3.3 spiked COVID-19 resequencing microarray β-actin human coronavirus human immunodeficiency virus distinguish blood
42 adult acute respiratory syndrome coronavirus 2 sars-coronavirus nostril reduction eleven surgery produce outlet microorganisms conversion IBV clinically stable causal 1
43 addition sputum posterior concordance MPV respiratory swabs diagnostic methods mers-cov rna live virus hrvs standard deviation taiwan typed influenzae neutropenia
44 aim viral rnas enzyme self-collection children parvoviruses hcov-229e RM-PCR worker-collected bal fluid terms sending brain tissue MS2 reduced
45 polymerase chain reaction anal swabs feb self-swabs lower exposure to 106 negative test N1 conjunctivitis 95 faeco-oral rhinometry 1229 officially
46 design corona guangdong anterior UTM classified polyomavirus highlight sars‐cov‐2 rejection prospective human parechovirus questionnaires preliminary deoxyribonucleic
47 frequently pharyngeal swab peripheral blood nylon 10(5 fecal polyomaviruses PK wild hexon onset titres exhaled post-bmt peaking
48 investigated scan titers saliva historical detected 5.4 data saliva samples J. chest tightness FHV-1 archived microbe paired samples
49 molecular 2019-ncov nucleic acid virus culture testing jan hcov 2007 coronavirus objects culture interquartile association hiv infection central nervous system orfa1ab
50 17 nasopharyngeal seropositive feasible medium NG nasal swabs values day-14 pneumonia viral isolation sampling AIDS log inaccurate